Loading...
Loncastuximab tesirine in relapsed/refractory high-grade B-cell lymphoma: a subgroup analysis from the LOTIS-2 study
Alderuccio, J. P. Ai, W. Z. Radford, John A Solh, M. M. Ardeshna, K. M. Lunning, M. Hess, B. Luigi Zinzani, P. Stathis, A. Carlo-Stella, C
Alderuccio, J. P.
Ai, W. Z.
Radford, John A
Solh, M. M.
Ardeshna, K. M.
Lunning, M.
Hess, B.
Luigi Zinzani, P.
Stathis, A.
Carlo-Stella, C
Citations
Altmetric:
Abstract
Description
Date
2022
Publisher
Collections
Files
Keywords
Type
Article
Citation
Alderuccio JP, Ai WZ, Radford J, Solh MM, Ardeshna KM, Lunning M, et al. Loncastuximab tesirine in relapsed/refractory high-grade B-cell lymphoma: a subgroup analysis from the LOTIS-2 study. Blood advances. 2022 Jul 5. PubMed PMID: 35790100. Epub 2022/07/06. eng.